✦ LIBER ✦

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)

✍ Scribed by Anna Sowa-Staszczak; Dorota Pach; Robert Chrzan; Małgorzata Trofimiuk; Agnieszka Stefańska; Monika Tomaszuk; Maciej Kołodziej; Renata Mikołajczak; Dariusz Pawlak; Alicja Hubalewska-Dydejczyk

Publisher: Springer
Year: 2011
Tongue: English
Weight: 351 KB
Volume: 38
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00259-011-1835-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decreased selenium levels after peptide

Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status

✍ Roy Moncayo; Annette Traeger 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 61 KB

Comparison of sequential planar177Lu-DOT

Comparison of sequential planar177Lu-DOTA-TATE dosimetry scans with68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy

✍ Aurora Sainz-Esteban; Vikas Prasad; Christiane Schuchardt; Carolin Zachert; José 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 444 KB